Conjugated linoleic acid (CLA), a mixture of positional and geometric isomers of linoleic acid, has attracted considerable attention because of its potentially beneficial biologic effects both in vitro and in vivo. Our results clearly show the specific action of the 10trans,12cis-CLA isomer against hyperlipidemia and obesity in obese Otsuka Long-Evans Tokushima Fatty (OLETF) rats. After 2 weeks of feeding with 10t,12c-CLA, but not 9cis,11trans-CLA, abdominal adipose tissue weight and serum and hepatic lipid levels in OLETF rats were lower than those in linoleic acid-fed rats. These effects were attributable to suppressed fatty acid synthesis and enhanced fatty acid beta oxidation in the liver on a 10t,12c-CLA diet. Additionally, we showed that mRNA expression of fatty acid synthase, carnitine palmitoyltransferase, leptin, and sterol regulatory element binding protein-1 was also regulated by 10t,12c-CLA. We suppose that 10t,12c-CLA reveals hypolipidemic and anti-obese activity through the alteration of mRNA expressions in the liver and white adipose tissue.
Lifestyle-related diseases, such as hyperlipidemia, arteriosclerosis, diabetes mellitus, and hypertension, are widespread and increasingly prevalent diseases in industrialized countries and contribute to the increase in cardiovascular morbidity and mortality. 1, 2) Accompanied by the rapid increase in the number of elderly people, this becomes important not only medically but also socioeconomically. Although the pathogenesis of lifestyle-related diseases is complicated and the precise mechanisms have not been elucidated, obesity has emerged as one of the major cardiovascular risk factors according to epidemiologic studies. [3] [4] [5] Obesity is defined as an increased mass of adipose tissue, and its prevalence and severity are markedly increasing in westernized countries. Although diet, especially dietary fat, has been recognized as contributing to the development and prevention of obesity, differential effects have arisen with respect to individual fatty acids. [6] [7] [8] [9] CLA refers to a mixture of positional and geometric isomers of linoleic acid with conjugated double bonds that is found in meat and dairy products, such as beef, milk, and processed cheese. 10, 11) CLA has attracted considerable attention because of its potentially beneficial biologic effects in inhibiting carcinogenesis and attenuating atherosclerosis in animal models. [12] [13] [14] It has also been reported that CLA reduces body fat and enhances lean body mass in animal models and that dietary CLA supplementation reduces the percentage of body fat compared with control groups in humans. [15] [16] [17] [18] The double bonds of CLA can be in position 7,9; 8,10; 9,11; 10,12; or 11,13 with multiple combinations of cis or trans (or both) configurations. Most studies of this fatty acid have used a mixture of CLA isomers because of its commercial availability. The major CLA isomers in the mixture are 9cis,11trans-CLA (9c,11t-CLA) and 10trans,12cis-CLA (10t,12c-CLA), whereas the other isomers are present at low concentrations. 19, 20) Growing evidence, however, indicates that individual isomers of CLA have specific physiological functions. [21] [22] [23] [24] We have reported elsewhere that the 10t,12c-CLA isomer, but not other isomers, reduces apolipoprotein B100 secretion in cultured human hepatoma Hep G2 cells. 25) In the present study, we investigated the effects of the positional difference of conjugated double bonds bey To whom correspondence should be addressed. Fax: +81-952-28-8782; E-mail: yanagitt@cc.saga-u.ac.jp Abbreviations: CLA, conjugated linoleic acid; CPT, carnitine palmitoyltransferase; FAS, fatty acid synthase; GAPDH, glyceraldehydes-3-phosphate dehydrogenase; LETO, Long-Evans Tokushima Otsuka; NEFA, non esterified fatty acid; OLETF, Otsuka Long-Evans Tokushima Fatty; PPAR, peroxisome proliferator activated receptor alpha; SREBP, sterol regulatory element binding protein; UCP, uncoupling protein; WAT, white adipose tissue tween 9c,11t and 10t,12c on the anti-obese and hypolipidemic effects of CLA in Otsuka Long-Evans Tokushima fatty (OLETF) rats. OLETF rats develop a syndrome with multiple metabolic and hormonal disorders that shares many features with human obesity. [26] [27] [28] [29] OLETF rats have hyperphagia, because they lack receptors for cholecystokinin, and become obese, developing hyperlipidemia, diabetes, and hypertension. To clarify the differences in the effects of CLA isomers, we compared their enzyme activity and gene expression in relation to lipid metabolism in these obese rats.
Materials and Methods
Animals and diets. Five-week-old male OLETF and Long-Evans Tokushima Otsuka (LETO) rats were provided by Tokusima Research Institute (Otsuka Pharmaceutical, Tokushima, Japan). LETO rats were used as the genetic controls of OLETF rats. Rats were housed individually in metal cages in a temperaturecontrolled room (24 C) under a 12-h light/dark cycle. After a 1-week adaptation period on a powder chow diet (CE-2, Clea Japan, Tokyo), OLETF rats were assigned to three groups (six rats each) that were pair-fed with a semisynthetic diet supplemented with 10% safflower oil (the control group), a semisynthetic diet supplemented with 9% safflower oil and 1% 9cis,11trans-CLA-rich oil (the 9c,11t-CLA group), or a semisynthetic diet supplemented with 9% safflower oil and 1% 10trans,12cis-CLA-rich oil (the 10t,12c-CLA group). LETO rats, the progenitor of OLETF rats, were fed the same diet as the OLETF rats in the control group. Both oils rich in each CLA-isomer were prepared by lipase-catalyzed selective esterification.
30) The composition of the semisynthetic diet and its fatty acid content are given in Table 1 . Because our previous study using OLETF rats showed that the anti-obese and hypolipidemic effect of CLA appeared from an early stage, 31, 32) the animals received different diets for 2 weeks. All rats were killed by aortic exsanguination under diethyl ether anesthesia. Abdominal (perirenal, epididymal, and omental) white adipose tissues (WATs) and west subcutaneous WAT were also excised for analysis. All aspects of the experiment were conducted according to the guidelines provided by the ethical committee on experimental animal care at Saga University.
Lipid analysis. Serum was separated by centrifuging the blood at 1750 Â g for 15 min. Triacylglycerol, cholesterol, glucose, and non-esterified fatty acid (NEFA) in serum were measured using enzyme assay kits from Wako Pure Chemicals (Tokyo). Serum leptin and insulin levels were measured using commercial rat enzyme-linked immunosorbent assay (ELISA) kits (Rat Leptin ELISA kit from the Yanaihara Institute, Fujinomiya, and Rat Insulin ELISA kit from the Morinaga, Yokohama, respectively). Liver lipids were extracted and purified according to the method of Folch et al.
33) The concentrations of triacylglycerol and cholesterol were measured according to the methods of Fletcher 34) and Sperry and Webb.
35)
Preparation of liver subcellular fractions. A piece of liver was homogenized in 6 volumes of a 0.25 M sucrose solution that contained 1 mM ethylene diamine tetraacetic acid (EDTA) in a 10 mM tris (hydroxymethyl) aminomethane-HCl (Tris-HCl) buffer (pH 7.4). After precipitating the nuclei fraction, the supernatant as centrifuged at 10;000 Â g for 10 min at 4
C to obtain mitochondria. The resulting supernatant was recentrifuged at 125;000 Â g for 60 min to precipitate microsomes, and the remaining supernatant was used as the cytosol fraction. The mitochondrial and microsomal pellets were resuspended in a 0.25 M sucrose solution that contained 1 mM EDTA in a 10 mM Tris-HCl buffer (pH 7.4). The protein concentration was determined according to the method of Lowry et al., 36) with bovine serum albumin used as the standard.
Assays of enzyme activity. The activity of fatty acid synthase (FAS) in the hepatic cytosomal fraction was measured according to the method of Kelley et al.
37) The reaction mixture consisted of 0.5 M potassium phosphate buffer (pH 7.0) that contained 200 mM reduced nicotinamide adenine dinucleotide phosphate (NADPH), 66 mM acetyl-coenzyme (CoA), and 200 mM malonyl-CoA. This mixture was placed in a cuvette and mixed with the enzyme. The reaction was observed spectrophotometrically at 340 nm for 5 min. A control reaction without substrate was also done. The plots of absorbance versus time were converted to nanomoles of NADPH reduction per min, using a millimolar extinction coefficient of 6.22.
The activity of carnitine palmitoyltransferase (CPT) in the hepatic mitochondrial fraction was measured according to the method of Markwell et al.
38) The reaction mixture contained 58 mM Tris-HCl buffer (pH 8.0), 1.25 mM EDTA, 0.1% Triton X-100, 0.25 mM 5,5 0 -dithiobis-(2-nitrobenzoic) acid (DTNB), and 37.5 mM palmitoyl-CoA. This mixture was placed in a cuvette and mixed with the enzyme. The reaction was started by the addition of 1.25 mM L-carnitine and was observed spectrophotometrically at 412 nm for 5 min. A control reaction without substrate was also done. The plots of absorbance versus time were converted to nanomoles of CoA-SH release per min, using a millimolar extinction coefficient of 13,600.
Determination of mRNA levels from liver and adipose tissue. Total cellular RNA was isolated from liver and adipose tissue samples using the Trizol reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's recommended procedures. Thirty micrograms total RNA from liver was electrophoresed onto a 0.22 M formaldehyde agarose gel, and the separated RNA fragments were transferred to a nylon membrane (Hybond-N þ ; Amersham, Piscataway, NJ). Membranes were subsequently hybridized overnight with random-primed 32 Plabeled cDNA probes (multiprime DNA labeling system; Amersham) or digoxigenin-labeled RNA probes (DIG-UTP RNA labeling kit; Roche Diagnostics, Mannheim, Germany 39) Differences were considered to be significant at P < 0:05.
Results
After the 2-week feeding period, the amount of food intake (264 AE 1 g) and final body weight (313 AE 3 g) was significantly higher in control diet-fed OLETF rats than in LETO rats (food intake
The effect of dietary CLA isomers on the distribution of lipids to the abdominal and subcutaneous WATs was investigated (Fig. 1) . It was apparent that OLETF rats developed marked abdominal obesity after 2 weeks of feeding of the diets. Compared with LETO rats, the control diet increased the weights significantly in abdominal (sum of perirenal, epididymal, and omental) WAT, but not significantly in subcutaneous WAT, in OLETF rats. Two weeks of feeding of the 10t,12c-CLA diet, but not the 9c,11t-CLA diet, significantly suppressed abdominal WAT accumulation. The perirenal, epididymal, and omental WAT weights of 10t,12c-CLAfed OLETF rats were reduced by 74%, 83%, and 89% respectively as compared with those of OLETF rats that were fed the control diet. These results show that the anti-obesity effect of CLA can be attributed to the effect of 10t,12c-CLA isomer on abdominal WAT. After the 2-week feeding period, 8-week-old OLETF rats showed mild hyperlipidemia. The serum triacylglycerol concentration was higher in control diet-fed Rats were fed a control, 9c,11t-CLA, or 10t,12c-CLA diet for 2 weeks. Values are expressed as mean AE SE for six rats. Table 1 lists the compositions of the diets. The asterisk indicates a significant (P < 0:05) difference between LETO and OLETF rats fed the control diet.
a,b Different letters show significant (P < 0:05) differences among groups of OLETF rats.
OLETF rats than in LETO rats ( Table 2 ). The triacylglycerol level was 19% lower, but not significant, in 10t,12c-CLA-fed rats than in rats fed the control diet. Serum cholesterol levels of OLETF rats fed the control diet were also significantly higher than those of LETO rats fed the control diet. The cholesterol concentration in rats fed the 10t,12c-CLA diet was lowest, but not significantly, among three groups of OLETF rats. Serum glucose and NEFA levels were higher in OLETF rats and were not significantly altered by dietary CLA isomers. There was no significant difference in the serum insulin level between LETO and OLETF rats or among the groups of OLETF rats. The 10t,12c-CLA feeding showed a significant effect on serum leptin level. As shown in Fig. 2A , the leptin level was 4.8-fold higher in OLETF rats fed the control diet as compared with LETO rats, which indicates the development of hyperleptinemia in the OLETF rats. In contrast to OLETF rats fed the control diet, however, the 10t,12c-CLA diet, but not the 9c,11t-CLA diet, significantly suppressed the development of hyperleptinemia. Figure 2B indicates that the onset of hyperleptinemia in OLETF rats is due not only to accumulated amounts of abdominal WAT but also to enhanced expression of leptin mRNA in abdominal WAT. The results also showed that the alleviation of hyperleptinemia by 10t,12c-CLA was attributable to the suppression of leptin mRNA expression in abdominal WAT.
Next, we investigated the effect of dietary CLA isomers on the distribution of lipids to the liver. There was no significant difference in liver weight among the groups of OLETF rats (control, 3:40 AE 0:11; 9c,11t-CLA, 3:33 AE 0:07; 10t,12c-CLA, 3:53 AE 0:08 g/100 g body weight). As shown in Fig. 3A , the triacylglycerol concentration in OLETF rats was significantly higher than in LETO rats, and the triacylglycerol accumulation in the liver of OLETF rats was markedly alleviated by the 10t,12c-CLA diet. There was no significant difference in liver cholesterol concentration between LETO and OLETF rats fed the control diet (Fig. 3B) , but the cholesterol concentration of OLETF rats fed the 10t,12c-CLA was significantly (17%) lower than that of OLETF rats fed the control diet. These results suggest that the 10t,12c-CLA diet can prevent hepatic lipid accumulation.
To investigate further the regulation of hepatic lipid metabolism, we analyzed the effect of dietary CLA isomers on the activities of enzymes related to fatty acid synthesis and fatty acid beta oxidation. As shown in Fig. 4A , the activity of FAS, a key enzyme of fatty acid synthesis, was markedly increased in OLETF rats fed the control diet as compared with LETO rats. This increase, however, was significantly suppressed by the 10t,12c-CLA diet in OLETF rats. Although the activity The asterisk shows a significant difference between LETO and OLETF rats fed the control diet at P < 0:05. a,b Different superscript letters show significant differences in OLETF rats at P < 0:05. Rats were fed a control, 9c,11t-CLA, or 10t,12c-CLA diet for 2 weeks. Values are expressed as mean AE SE for six rats. Table 1 lists the compositions of the diets. The asterisk indicates a significant (P < 0:05) difference between LETO and OLETF rats fed the control diet.
a,b Different letters show significant (P < 0:05) differences among groups of OLETF rats. Rats were fed a control, 9c,11t-CLA, or 10t,12c-CLA diet for 2 weeks. Values are expressed as mean AE SE for six rats. Table 1 lists the compositions of the diets. The asterisk indicates a significant (P < 0:05) difference between LETO and OLETF rats fed the control diet.
of CPT, a key enzyme of fatty acid beta oxidation, was not different between the OLETF and LETO rats, the 10t,12c-CLA diet significantly enhanced the activity compared with the control diet in OLETF rats (Fig. 4B ). These results demonstrate that the hypolipidemic effect of 10t,12c-CLA can be attributed to reduced FAS activity and enhanced CPT activity in the liver.
To gain insight into the effect of dietary CLA isomers on the levels of mRNA related to lipid metabolism, we analyzed the hepatic mRNA expression of lipogenic genes by northern-blot hybridization (Fig. 5) . The mRNA expression of FAS and CPT was changed by the 10t,12c-CLA diet, and no significant effect was shown by the 9c,11t-CLA diet. Hepatic mRNA levels of UCP-2, a mitochondrial membrane transporter that regulates thermogenesis, were similar in LETO and OLETF rats fed the control diet. In OLETF rats, dietary CLAs enhanced UCP-2 mRNA expression by 1.3-fold as compared with the control diet, whereas no difference was seen between rats fed the 9c,11t-CLA and the 10t,12c-CLA diet. SREBP-1, a membrane-bound transcriptional factor, regulates the gene expression of enzymes concerning biosynthesis of fatty acids such as FAS and acetyl-CoA carboxylase. The mRNA expression of SREBP-1 was significantly higher in OLETF rats fed the control diet than in LETO rats, and the expression was significantly suppressed by the 10t,12c-CLA diet in OLETF rats. These results suggest that 10t,12c-CLA prevents hepatic lipid accumulation through a decrease in fatty acid synthesis with decreased levels of SREBP-1 mRNA expression.
Discussion
We investigated the effects of the positional difference in conjugated double bonds between 9c,11t and 10t,12c on the physiological effects of CLA in obese OLETF rats. The results showed that 10t,12c-CLA reveals anti-obese and hypolipidemic actions concomitant with the alteration of mRNA expressions in the liver and WAT.
In the past few decades, numerous health benefits of CLA have been reported in experimental animals and humans, including protective effects against obesity, atherosclerosis, and cancer. [12] [13] [14] [15] [16] [17] [18] In contrast, speciesspecific responses have been reported that feeding CLA mixture or 10t,12c-CLA with low-fat diet increased hepatic lipid contents in mice, concomitant with a decrease in body fat mass. 40, 41) We, however, have previously reported that a mixture of CLA isomers in the diet lowered both serum and hepatic triacylglycerol levels without the development of a fatty liver in OLETF rats, unlike in mice. 31, 32, [42] [43] [44] In the present study, dietary 10t,12c-CLA significantly lowered hepatic triacylglycerol levels, and dietary 9c,11t-CLA was also not a cause of fatty liver in OLETF rats. These results suggest that this animal model is suitable for the evaluation of the effect of CLA because supplementation with CLA does result in any symptoms of fatty liver in humans. 45, 46) It should also be noted that increasing the amount of fat in CLA-supplemented diet substantially reduces the fatty liver effect of CLA in mice. 47) Our previous work showed that a mixture of CLA isomers decreased abdominal WAT weights and serum and hepatic triacylglycerol levels by enhancing fatty acid beta oxidation and suppressing fatty acid synthesis in WAT and liver of OLETF rats. 31, 32, [42] [43] [44] In addition, fatty acid beta oxidation was enhanced even in brown adipose tissue and muscle. 42) Consistent with these previous results, dietary 10t,12c-CLA, but not 9c,11t-CLA, significantly increased the activity of hepatic CPT, a key enzyme of fatty acid beta oxidation, as compared with the control diet in OLETF rats. The hepatic mRNA level of CPT was also significantly increased by dietary Rats were fed a control, 9c,11t-CLA, or 10t,12c-CLA diet for 2 weeks. Values are expressed as mean AE SE for six rats. Table 1 lists the compositions of the diets. The asterisk indicates a significant (P < 0:05) difference between LETO and OLETF rats fed the control diet.
10t,12c-CLA as compared with the control diet. In addition, hepatic mRNA levels of UCP-2, a proposed thermogenic regulator, were increased by both dietary CLA isomers. These results suggest that enhanced fatty acid beta oxidation and thermogenesis by dietary 10t,12c-CLA might be partially responsible for the hypolipidemic effect of a mixture of CLA isomers. Peroxisome proliferators-activated receptor alpha (PPAR), one of the nuclear receptors related to the modulation of environmental and dietary stimuli, 48) is likely to be involved in the regulation of the gene expression of fatty acid beta oxidation enzymes by dietary CLA. It has been demonstrated that CLA is a potent ligand and activator of PPAR, 49) but Peters et al. 50) observed that a mixture of CLA isomers increased the gene expression of hepatic fatty acid beta oxidation enzymes through both PPAR-dependent and -independent mechanisms. The precise mechanisms of transcriptional regulation of fatty acid beta oxidation enzymes remain to be elucidated.
The activity of FAS, a key enzyme of fatty acid synthesis, was also significantly decreased by dietary 10t,12c-CLA as compared with the control diet in the liver of OLETF rats. Dietary 9c,11t-CLA, however, did not show a significant effect on the activities of those enzymes. Although slight changes were seen in the enzyme activity of the 9c,11t-CLA group, a precise evaluation of 9c,11t-CLA itself on those enzyme activities will be carried out in a future study. The gene expression of FAS is regulated by SREBP-1, a lipogenic transcriptional factor. The mature nuclear form of SREBP is produced from the membrane-bound precursor by proteolytic cleavage. 51) Thus the nuclear content of mature SREBP is under the regulation of gene expression and proteolytic cleavage of the precursor. In the present study, we showed that 10t,12c-CLA decreased SREBP-1 mRNA expression, which suggests that this isomer can decrease fatty acid synthesis through the suppression of SREBP-1 signaling.
In addition, the marked difference between LETO and OLETF rats was shown in enhanced fatty acid synthesis through an activation of FAS activity and increased mRNA expression of FAS and SREBP-1. There was no alteration in CPT or UCP-2 mRNA, which are expressed under the transcriptional regulation of PPAR, between the two strains. Takahashi et al. 41) reported that dietary CLA increases hepatic lipid accumulation despite a concomitant increase in the activity and mRNA levels involved in fatty acid synthesis and beta oxidation in the mouse liver. They suggested that the up-regulation of SREBP-1 might be responsible for hepatic lipid accumulation in mice. Hence we speculate that the responsibility of SREBP-1 rather than PPAR might be a main cause of strain and species differences in local lipid distribution to the liver.
A significant effect of dietary 10t,12c-CLA was also shown in the suppression of serum leptin levels. We also showed isomer-specific suppression in 10t,12c-CLA on leptin mRNA in abdominal WAT. This result is consistent with previous work of Kang et al. 52) showing that 10t,12c-CLA reduced leptin mRNA levels in 3T3-L1 adipocytes and the abdominal adipose tissue of ICR mice. Although the regulatory mechanism of leptin production during the onset of obesity is not clear, the incidence of hyperleptinemia is suspected to be a cause of other metabolic disorders, such as diabetes, atherosclerosis, and hypertension. 53, 54) Thus the suppressive effect of dietary 10t,12c-CLA on leptin production might contribute to the prevention of the development of a multiple-risk cluster syndrome.
In summary, we have shown that the dietary 10t,12c-CLA isomer, as compared with a linoleic acid-rich control diet, significantly suppressed abdominal adipose tissue and lipids in the liver of OLETF rats. These effects were attributable to the enhancement of fatty acid beta oxidation and suppression of fatty acid synthesis concomitant with an alteration in mRNA expression.
